Antiseizure medication choice in diffuse glioma: A single‐center population‐based experience
Abstract Objective Several antiseizure medications (ASMs) can be considered as first‐line treatment for glioma‐associated epilepsy (GAE). We aimed to find out, if there are subgroups of glioma patients which may benefit from different first‐line ASMs. Methods All diffuse glioma (grade 2–4) patients,...
Збережено в:
| Автори: | , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Wiley
2025-06-01
|
| Серія: | Epilepsia Open |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1002/epi4.70007 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|